Logo image of KRN.DE

KRONES AG (KRN.DE) Stock Fundamental Analysis

FRA:KRN - Deutsche Boerse Ag - DE0006335003 - Common Stock - Currency: EUR

143.2  +2.8 (+1.99%)

Fundamental Rating

6

KRN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. KRN scores excellent on profitability, but there are some minor concerns on its financial health. KRN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year KRN was profitable.
KRN had a positive operating cash flow in the past year.
KRN had positive earnings in 4 of the past 5 years.
In the past 5 years KRN always reported a positive cash flow from operatings.
KRN.DE Yearly Net Income VS EBIT VS OCF VS FCFKRN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

KRN has a Return On Assets of 5.83%. This is in the better half of the industry: KRN outperforms 77.98% of its industry peers.
KRN has a Return On Equity of 14.45%. This is amongst the best in the industry. KRN outperforms 83.49% of its industry peers.
With an excellent Return On Invested Capital value of 11.58%, KRN belongs to the best of the industry, outperforming 87.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KRN is above the industry average of 8.05%.
The last Return On Invested Capital (11.58%) for KRN is above the 3 year average (10.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.83%
ROE 14.45%
ROIC 11.58%
ROA(3y)5.11%
ROA(5y)3.35%
ROE(3y)13.07%
ROE(5y)8.54%
ROIC(3y)10.37%
ROIC(5y)N/A
KRN.DE Yearly ROA, ROE, ROICKRN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

KRN has a better Profit Margin (5.25%) than 64.22% of its industry peers.
In the last couple of years the Profit Margin of KRN has grown nicely.
With a Operating Margin value of 7.09%, KRN perfoms like the industry average, outperforming 58.72% of the companies in the same industry.
In the last couple of years the Operating Margin of KRN has grown nicely.
KRN's Gross Margin of 52.57% is fine compared to the rest of the industry. KRN outperforms 68.81% of its industry peers.
In the last couple of years the Gross Margin of KRN has remained more or less at the same level.
Industry RankSector Rank
OM 7.09%
PM (TTM) 5.25%
GM 52.57%
OM growth 3Y13.3%
OM growth 5Y31.4%
PM growth 3Y10.38%
PM growth 5Y85.26%
GM growth 3Y0.06%
GM growth 5Y0.84%
KRN.DE Yearly Profit, Operating, Gross MarginsKRN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KRN is still creating some value.
The number of shares outstanding for KRN remains at a similar level compared to 1 year ago.
The number of shares outstanding for KRN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, KRN has an improved debt to assets ratio.
KRN.DE Yearly Shares OutstandingKRN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KRN.DE Yearly Total Debt VS Total AssetsKRN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

The Debt to FCF ratio of KRN is 0.01, which is an excellent value as it means it would take KRN, only 0.01 years of fcf income to pay off all of its debts.
KRN has a better Debt to FCF ratio (0.01) than 100.00% of its industry peers.
KRN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, KRN belongs to the top of the industry, outperforming 98.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC1.64
WACC7.04%
KRN.DE Yearly LT Debt VS Equity VS FCFKRN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.36 indicates that KRN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.36, KRN is not doing good in the industry: 61.47% of the companies in the same industry are doing better.
KRN has a Quick Ratio of 1.10. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
KRN has a Quick ratio (1.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.1
KRN.DE Yearly Current Assets VS Current LiabilitesKRN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.60% over the past year.
The Earnings Per Share has been growing by 96.42% on average over the past years. This is a very strong growth
The Revenue has grown by 14.42% in the past year. This is quite good.
The Revenue has been growing slightly by 5.98% on average over the past years.
EPS 1Y (TTM)26.6%
EPS 3Y25.19%
EPS 5Y96.42%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.42%
Revenue growth 3Y13.35%
Revenue growth 5Y5.98%
Sales Q2Q%13.06%

3.2 Future

Based on estimates for the next years, KRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.00% on average per year.
The Revenue is expected to grow by 5.20% on average over the next years.
EPS Next Y18.02%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
EPS Next 5Y13%
Revenue Next Year8.08%
Revenue Next 2Y7.33%
Revenue Next 3Y7.1%
Revenue Next 5Y5.2%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
KRN.DE Yearly Revenue VS EstimatesKRN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KRN.DE Yearly EPS VS EstimatesKRN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

KRN is valuated correctly with a Price/Earnings ratio of 15.75.
64.22% of the companies in the same industry are more expensive than KRN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.43. KRN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 12.12, KRN is valued correctly.
KRN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.17. KRN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.75
Fwd PE 12.12
KRN.DE Price Earnings VS Forward Price EarningsKRN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRN is valued a bit cheaper than the industry average as 66.06% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KRN is valued a bit cheaper than 61.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.57
EV/EBITDA 6.86
KRN.DE Per share dataKRN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

KRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KRN has an outstanding profitability rating, which may justify a higher PE ratio.
KRN's earnings are expected to grow with 14.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.87
PEG (5Y)0.16
EPS Next 2Y16.09%
EPS Next 3Y14.61%

5

5. Dividend

5.1 Amount

KRN has a Yearly Dividend Yield of 1.85%.
KRN's Dividend Yield is a higher than the industry average which is at 2.75.
KRN's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

The dividend of KRN has a limited annual growth rate of 5.29%.
Dividend Growth(5Y)5.29%
Div Incr Years1
Div Non Decr Years4
KRN.DE Yearly Dividends per shareKRN.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

24.24% of the earnings are spent on dividend by KRN. This is a low number and sustainable payout ratio.
The dividend of KRN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.24%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
KRN.DE Yearly Income VS Free CF VS DividendKRN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRN.DE Dividend Payout.KRN.DE Dividend Payout, showing the Payout Ratio.KRN.DE Dividend Payout.PayoutRetained Earnings

KRONES AG

FRA:KRN (6/4/2025, 7:00:00 PM)

143.2

+2.8 (+1.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners22.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.52B
Analysts80
Price Target151.69 (5.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend2.2
Dividend Growth(5Y)5.29%
DP24.24%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.43%
Min EPS beat(2)-7.42%
Max EPS beat(2)-1.44%
EPS beat(4)1
Avg EPS beat(4)6.57%
Min EPS beat(4)-18.73%
Max EPS beat(4)53.89%
EPS beat(8)3
Avg EPS beat(8)2.47%
EPS beat(12)7
Avg EPS beat(12)9.22%
EPS beat(16)11
Avg EPS beat(16)12.7%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)0.64%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)1.67%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)0.62%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)0%
PT rev (3m)1.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.39%
Revenue NQ rev (1m)-0.7%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE 15.75
Fwd PE 12.12
P/S 0.83
P/FCF 17.57
P/OCF 10.18
P/B 2.28
P/tB 3.21
EV/EBITDA 6.86
EPS(TTM)9.09
EY6.35%
EPS(NY)11.82
Fwd EY8.25%
FCF(TTM)8.15
FCFY5.69%
OCF(TTM)14.06
OCFY9.82%
SpS172.73
BVpS62.82
TBVpS44.56
PEG (NY)0.87
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 5.83%
ROE 14.45%
ROCE 15.97%
ROIC 11.58%
ROICexc 15.32%
ROICexgc 22.37%
OM 7.09%
PM (TTM) 5.25%
GM 52.57%
FCFM 4.72%
ROA(3y)5.11%
ROA(5y)3.35%
ROE(3y)13.07%
ROE(5y)8.54%
ROIC(3y)10.37%
ROIC(5y)N/A
ROICexc(3y)13.79%
ROICexc(5y)N/A
ROICexgc(3y)19.27%
ROICexgc(5y)N/A
ROCE(3y)14.31%
ROCE(5y)N/A
ROICexcg growth 3Y22.07%
ROICexcg growth 5Y40.08%
ROICexc growth 3Y16.88%
ROICexc growth 5Y36.18%
OM growth 3Y13.3%
OM growth 5Y31.4%
PM growth 3Y10.38%
PM growth 5Y85.26%
GM growth 3Y0.06%
GM growth 5Y0.84%
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 107.25%
Cap/Sales 3.42%
Interest Coverage 58.35
Cash Conversion 79.18%
Profit Quality 89.82%
Current Ratio 1.36
Quick Ratio 1.1
Altman-Z N/A
F-Score8
WACC7.04%
ROIC/WACC1.64
Cap/Depr(3y)96.01%
Cap/Depr(5y)83.18%
Cap/Sales(3y)3.22%
Cap/Sales(5y)3.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.6%
EPS 3Y25.19%
EPS 5Y96.42%
EPS Q2Q%15.38%
EPS Next Y18.02%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
EPS Next 5Y13%
Revenue 1Y (TTM)14.42%
Revenue growth 3Y13.35%
Revenue growth 5Y5.98%
Sales Q2Q%13.06%
Revenue Next Year8.08%
Revenue Next 2Y7.33%
Revenue Next 3Y7.1%
Revenue Next 5Y5.2%
EBIT growth 1Y29.71%
EBIT growth 3Y28.43%
EBIT growth 5Y39.26%
EBIT Next Year64.77%
EBIT Next 3Y25.33%
EBIT Next 5Y15.11%
FCF growth 1Y0.15%
FCF growth 3Y3.15%
FCF growth 5YN/A
OCF growth 1Y15.52%
OCF growth 3Y8.72%
OCF growth 5Y35.97%